Insights

Strategic partnerships Vascudyne operates at the intersection of tissue engineering and device development with an end-to-end platform, suggesting strong opportunities for collaboration with medical device manufacturers, contract research organizations, and healthcare systems seeking regenerative therapies for cardiovascular conditions.

Clinical validation Recent presentations at ICC 2025, AHA Scientific Sessions, and Heart Valve Society indicate active preclinical and early clinical data generation for bioengineered vascular and valve solutions, signaling potential in-building clinical evidence and payer-ready value propositions for CABG and valve therapies.

Regulatory readiness The company emphasizes comprehensive regulatory expertise as part of its platform, presenting a sales angle to hospitals and external device makers needing regulatory support and accelerated path to market for regenerative cardiovascular products.

Growth potential With a lean team and recent facility investments fueled by Series A funding, Vascudyne appears positioned for rapid scaling of manufacturing and customized device development, offering partnership opportunities for capacity expansion and co-development programs.

Clinical pipeline Active programs in tissue conduits, acellular vessels, and transcatheter pulmonary valves suggest multiple entry points for cross-sell into interventional cardiology, cardiac surgery, and congenital heart disease markets, as well as adjacent revenue streams from research and clinical collaborations.

Similar companies to Vascudyne

Vascudyne Tech Stack

Vascudyne uses 8 technology products and services including Hotjar, WordPress, Shopify, and more. Explore Vascudyne's tech stack below.

Media & News

Vascudyne's Email Address Formats

Vascudyne uses at least 1 email format:
Vascudyne Email FormatsExamplePercentage
FLast@vascudyne.comJDoe@vascudyne.com
100%

Frequently Asked Questions

What is Vascudyne's official website and social media links?

Minus sign iconPlus sign icon
Vascudyne's official website is vascudyne.com and has social profiles on LinkedIn.

How much revenue does Vascudyne generate?

Minus sign iconPlus sign icon
As of October 2026, Vascudyne's annual revenue is estimated to be $1M - $10M.

What is Vascudyne's NAICS code?

Minus sign iconPlus sign icon
Vascudyne's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Vascudyne have currently?

Minus sign iconPlus sign icon
As of October 2026, Vascudyne has approximately 13 employees across 1 continents, including North America. Key team members include Chief Executive Officer: Z. S., Ceo: K. S. and Director Of Clinical Affairs: A. K. Explore Vascudyne's employee directory with LeadIQ.

What industry does Vascudyne belong to?

Minus sign iconPlus sign icon
Vascudyne operates in the Medical Equipment Manufacturing industry.

What technology does Vascudyne use?

Minus sign iconPlus sign icon
Vascudyne's tech stack includes Hotjar, WordPress, Shopify, Microsoft 365, Google Fonts API, Google Cloud, KnowBe4 and WebFactory Maintenance.

What is Vascudyne's email format?

Minus sign iconPlus sign icon
Vascudyne's email format typically follows the pattern of FLast@vascudyne.com. Find more Vascudyne email formats with LeadIQ.
Vascudyne logo

Vascudyne

Medical Equipment ManufacturingMinnesota, United States11-50 Employees

Vascudyne develops bioengineered tissue solutions for cardiovascular medicine, working to restore heart and vascular function with living tissues. It positions itself as a leader in regenerative cardiovascular technology, offering an integrated platform that combines tissue engineering, device development, scalable manufacturing, and regulatory expertise. The company is based in St. Paul, Minnesota, and operates with a small to mid-sized team.

Its customers include healthcare innovators—researchers and developers pursuing cardiovascular therapies and devices—who collaborate with Vascudyne through end-to-end partnerships that move concepts toward patient care. In late 2025, the company participated in major cardiovascular conferences, presenting preclinical and early clinical data from its tissue-based graft programs for coronary bypass procedures and related vascular applications.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Vascudyne's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.